These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19680167)

  • 21. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease.
    Ye F; Foell D; Hirono KI; Vogl T; Rui C; Yu X; Watanabe S; Watanabe K; Uese K; Hashimoto I; Roth J; Ichida F; Miyawaki T
    Am J Cardiol; 2004 Sep; 94(6):840-4. PubMed ID: 15374807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
    Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
    Singapore Med J; 2006 Sep; 47(9):780-4. PubMed ID: 16924360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study.
    Teraguchi M; Ogino H; Yoshimura K; Taniuchi S; Kino M; Okazaki H; Kaneko K
    Pediatr Cardiol; 2013 Apr; 34(4):959-63. PubMed ID: 23184018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.
    Inoue Y; Okada Y; Shinohara M; Kobayashi T; Kobayashi T; Tomomasa T; Takeuchi K; Morikawa A
    J Pediatr; 2006 Sep; 149(3):336-341. PubMed ID: 16939743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and safety of glucocorticoids in addition to intravenous immunoglobulin in the initial treatment of Kawasaki disease: a meta-analysis of randomized trials].
    Hu JW; Zhou ZS; Yang L; Zheng CN; Wang KD
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1259-64. PubMed ID: 21756798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
    Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F; Ding Y; Yin W
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1109-12. PubMed ID: 24342209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
    Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
    Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of corticosteroid therapy in refractory Kawasaki patients.
    Al-Mayouf SM
    Clin Rheumatol; 2004 Feb; 23(1):11-3. PubMed ID: 14749974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH; Liu PM; Bong CN; Wu YT; Yang KD; Wang CL
    J Microbiol Immunol Infect; 2005 Apr; 38(2):149-52. PubMed ID: 15843862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of S100A12/TLR2 signaling molecules and clinical indicators in a new predictive model for IVIG-resistant Kawasaki disease.
    Wu Y; Liu P; Zhou Y; Yang Y; Li S; Yin W; Liu F; Ding Y
    Sci Rep; 2024 Mar; 14(1):7261. PubMed ID: 38538656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti TNF-α (infliximab) treatment for intravenous immunoglobulin (IVIG) resistance patients with acute Kawasaki disease the effects of anticytokine therapy].
    Saji T; Takatsuki S; Kobayashi T
    Nihon Rinsho; 2014 Sep; 72(9):1641-9. PubMed ID: 25518416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease.
    Wang Z; Chen F; Wang Y; Li W; Xie X; Liu P; Zhang X; Zhang L; Huang P
    J Immunol Res; 2020; 2020():4175821. PubMed ID: 33299898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.
    Ogata S; Shimizu C; Franco A; Touma R; Kanegaye JT; Choudhury BP; Naidu NN; Kanda Y; Hoang LT; Hibberd ML; Tremoulet AH; Varki A; Burns JC
    PLoS One; 2013; 8(12):e81448. PubMed ID: 24324693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
    Hung JJ; Chiu CH
    Ann Trop Paediatr; 2004 Mar; 24(1):89-93. PubMed ID: 15005973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
    Sánchez-Manubens J; Antón J; Bou R; Iglesias E; Calzada-Hernandez J; Borlan S; Gimenez-Roca C; Rivera J;
    Rheumatol Int; 2016 Jul; 36(7):905-10. PubMed ID: 27215220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.